BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31015157)

  • 1. GEC-ESTRO ACROP recommendations on calibration and traceability of LE-LDR photon-emitting brachytherapy sources at the hospital level.
    Perez-Calatayud J; Ballester F; Carlsson Tedgren Å; Rijnders A; Rivard MJ; Andrássy M; Niatsetski Y; Schneider T; Siebert FA
    Radiother Oncol; 2019 Jun; 135():120-129. PubMed ID: 31015157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GEC-ESTRO ACROP recommendations on calibration and traceability of HE HDR-PDR photon-emitting brachytherapy sources at the hospital level.
    Perez-Calatayud J; Ballester F; Carlsson Tedgren Å; DeWerd LA; Papagiannis P; Rivard MJ; Siebert FA; Vijande J
    Radiother Oncol; 2022 Nov; 176():108-117. PubMed ID: 36167195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supplement 2 for the 2004 update of the AAPM Task Group No. 43 Report: Joint recommendations by the AAPM and GEC-ESTRO.
    Rivard MJ; Ballester F; Butler WM; DeWerd LA; Ibbott GS; Meigooni AS; Melhus CS; Mitch MG; Nath R; Papagiannis P
    Med Phys; 2017 Sep; 44(9):e297-e338. PubMed ID: 28644913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GEC-ESTRO/ACROP recommendations for quality assurance of ultrasound imaging in brachytherapy.
    Siebert FA; Kirisits C; Hellebust TP; Baltas D; Verhaegen F; Camps S; Pieters B; Kovács G; Thomadsen B
    Radiother Oncol; 2020 Jul; 148():51-56. PubMed ID: 32335363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dosimetric uncertainty analysis for photon-emitting brachytherapy sources: report of AAPM Task Group No. 138 and GEC-ESTRO.
    DeWerd LA; Ibbott GS; Meigooni AS; Mitch MG; Rivard MJ; Stump KE; Thomadsen BR; Venselaar JL
    Med Phys; 2011 Feb; 38(2):782-801. PubMed ID: 21452716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AAPM and GEC-ESTRO guidelines for image-guided robotic brachytherapy: report of Task Group 192.
    Podder TK; Beaulieu L; Caldwell B; Cormack RA; Crass JB; Dicker AP; Fenster A; Fichtinger G; Meltsner MA; Moerland MA; Nath R; Rivard MJ; Salcudean T; Song DY; Thomadsen BR; Yu Y; ;
    Med Phys; 2014 Oct; 41(10):101501. PubMed ID: 25281939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procedures for establishing and maintaining consistent air-kerma strength standards for low-energy, photon-emitting brachytherapy sources: recommendations of the Calibration Laboratory Accreditation Subcommittee of the American Association of Physicists in Medicine.
    DeWerd LA; Huq MS; Das IJ; Ibbott GS; Hanson WF; Slowey TW; Williamson JF; Coursey BM;
    Med Phys; 2004 Mar; 31(3):675-81. PubMed ID: 15070265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GEC-ESTRO ACROP prostate brachytherapy guidelines.
    Henry A; Pieters BR; André Siebert F; Hoskin P;
    Radiother Oncol; 2022 Feb; 167():244-251. PubMed ID: 34999134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose calculation for photon-emitting brachytherapy sources with average energy higher than 50 keV: report of the AAPM and ESTRO.
    Perez-Calatayud J; Ballester F; Das RK; Dewerd LA; Ibbott GS; Meigooni AS; Ouhib Z; Rivard MJ; Sloboda RS; Williamson JF
    Med Phys; 2012 May; 39(5):2904-29. PubMed ID: 22559663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ESTRO-ACROP guideline: Interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost - GEC-ESTRO Breast Cancer Working Group practical recommendations.
    Strnad V; Major T; Polgar C; Lotter M; Guinot JL; Gutierrez-Miguelez C; Galalae R; Van Limbergen E; Guix B; Niehoff P; Lössl K; Hannoun-Levi JM
    Radiother Oncol; 2018 Sep; 128(3):411-420. PubMed ID: 29691075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric prerequisites for routine clinical use of photon emitting brachytherapy sources with average energy higher than 50 kev.
    Li Z; Das RK; DeWerd LA; Ibbott GS; Meigooni AS; Pérez-Calatayud J; Rivard MJ; Sloboda RS; Williamson JF; ;
    Med Phys; 2007 Jan; 34(1):37-40. PubMed ID: 17278487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GEC-ESTRO ACROP recommendations for head & neck brachytherapy in squamous cell carcinomas: 1st update - Improvement by cross sectional imaging based treatment planning and stepping source technology.
    Kovács G; Martinez-Monge R; Budrukkar A; Guinot JL; Johansson B; Strnad V; Skowronek J; Rovirosa A; Siebert FA;
    Radiother Oncol; 2017 Feb; 122(2):248-254. PubMed ID: 27889184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photon spectrometry for the determination of the dose-rate constant of low-energy photon-emitting brachytherapy sources.
    Chen ZJ; Nath R
    Med Phys; 2007 Apr; 34(4):1412-30. PubMed ID: 17500473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.
    Rivard MJ; Coursey BM; DeWerd LA; Hanson WF; Huq MS; Ibbott GS; Mitch MG; Nath R; Williamson JF
    Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Third-party brachytherapy source calibrations and physicist responsibilities: report of the AAPM Low Energy Brachytherapy Source Calibration Working Group.
    Butler WM; Bice WS; DeWerd LA; Hevezi JM; Huq MS; Ibbott GS; Palta JR; Rivard MJ; Seuntjens JP; Thomadsen BR
    Med Phys; 2008 Sep; 35(9):3860-5. PubMed ID: 18841836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The difference of scoring dose to water or tissues in Monte Carlo dose calculations for low energy brachytherapy photon sources.
    Landry G; Reniers B; Pignol JP; Beaulieu L; Verhaegen F
    Med Phys; 2011 Mar; 38(3):1526-33. PubMed ID: 21520864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GEC-ESTRO/ACROP recommendations for performing bladder-sparing treatment with brachytherapy for muscle-invasive bladder carcinoma.
    Pieters BR; van der Steen-Banasik E; Smits GA; De Brabandere M; Bossi A; Van Limbergen E
    Radiother Oncol; 2017 Mar; 122(3):340-346. PubMed ID: 28049550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy.
    Pötter R; Van Limbergen E; Gerstner N; Wambersie A
    Radiother Oncol; 2001 Jan; 58(1):11-8. PubMed ID: 11165676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GEC-ESTRO ACROP recommendations in skin brachytherapy.
    Guinot JL; Rembielak A; Perez-Calatayud J; Rodríguez-Villalba S; Skowronek J; Tagliaferri L; Guix B; Gonzalez-Perez V; Valentini V; Kovacs G;
    Radiother Oncol; 2018 Mar; 126(3):377-385. PubMed ID: 29455924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technical aspects of the integration of three-dimensional treatment planning dose parameters (GEC-ESTRO Working Group) into pre-implant planning for LDR gynecological interstitial brachytherapy.
    Chi A; Gao M; Nguyen NP; Albuquerque K
    Technol Cancer Res Treat; 2009 Jun; 8(3):181-6. PubMed ID: 19445535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.